While Laboratory Co News Today

Cypress Capital Group lessened its holdings in Laboratory Co. of America Holdings (NYSE:LH - Get Rating) by 12.1% in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 5,338 shares of the medical research company's s

Los Angeles Capital Management LLC cut its holdings in shares of Laboratory Co. of America Holdings (NYSE:LH - Get Rating) by 2.6% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 144,900 shares of the medical research c

Robert W. Baird lifted their price objective on shares of Laboratory Co. of America from $270.00 to $285.00 in a research note on Wednesday.

Laboratory Co. of America Holdings (NYSE:LH - Get Rating) was the recipient of a significant decline in short interest during the month of December. As of December 15th, there was short interest totalling 1,550,000 shares, a decline of 13.4% from the November 30th total of 1,790,000 shares. Currently, 1.8% of the company's stock are sold short. Based on an average daily trading volume, of 788,400 shares, the days-to-cover ratio is currently 2.0 days.

Laboratory Co. of America Holdings (NYSE:LH - Get Rating) has been given a consensus rating of "Moderate Buy" by the eleven analysts that are presently covering the stock, MarketBeat Ratings reports. Four equities research analysts have rated the stock with a hold recommendation and five have assig

Citigroup downgraded shares of Laboratory Co. of America from a "buy" rating to a "neutral" rating in a report on Monday.

Laboratory Co. of America Holdings (NYSE:LH - Get Rating) has received an average rating of "Moderate Buy" from the eleven ratings firms that are presently covering the stock, MarketBeat.com reports. Three equities research analysts have rated the stock with a hold rating and five have given a buy

Laboratory Co. of America Holdings (NYSE:LH - Get Rating) has been assigned an average rating of "Moderate Buy" from the eleven ratings firms that are currently covering the company, Marketbeat.com reports. Three equities research analysts have rated the stock with a hold recommendation and four ha

Laboratory Co. of America Holdings (NYSE:LH - Get Rating) was the recipient of a significant growth in short interest in September. As of September 15th, there was short interest totalling 1,840,000 shares, a growth of 18.7% from the August 31st total of 1,550,000 shares. Approximately 2.0% of the shares of the company are short sold. Based on an average daily trading volume, of 577,800 shares, the short-interest ratio is presently 3.2 days.

Laboratory Co. of America Holdings (NYSE:LH - Get Rating) - Research analysts at Zacks Research cut their FY2023 EPS estimates for Laboratory Co. of America in a research note issued on Wednesday, September 21st. Zacks Research analyst B. Das now anticipates that the medical research company will